Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers

Study acronym: TREAT2D
StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Jul 31, 2026 → Nov 15, 2026
See other at-risk trials from Daniel Chernavvsky, MD

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 4 more changesShow less
    • Primary completion pushed from Jul 31, 2026 to Nov 15, 2026
    • Study completion pushed from Jul 31, 2026 to Nov 17, 2026
    • Eligibility criteria expanded, about 17 words
    • Site details revised
  2. Start date changed from estimate of Oct 15, 2025 to Oct 28, 2025v4
  3. Start date: Sep 21, 2025 to Oct 15, 2025v3
  4. Lead sponsor: Anas El Fathi to Daniel Chernavvsky, MDv2 Show 4 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Start date: Aug 1, 2025 to Sep 21, 2025
    • Interventions: Control Group (Other), Experimental Group (Other) to Continuous Glucose Monitor (CGM) + Patient Centered Multi-Agent Decision Support System (PCM-DSS) (Other), Continuous Glucose Monitor (CGM)…
    • Site details revised
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Decision Support System (Software) for multi antidiabetic drug therapy use in type 2 diabetes (T2D).
Trial Details
NCT Number NCT07063420
Lead Sponsor Daniel Chernavvsky, MD
Collaborators: University of Virginia
Conditions
(from sponsor)		 Type 2 Diabetes Treated With Insulin
Enrollment 18 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov